Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in Moderate to Severe Traumatic Brain Injury
NCT07180277Phase 4Recruiting
- Sponsor
- Zhangjiagang First People's Hospital
- Start
- Mar 2026
- Primary completion
- Jan 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone injection in traumatic brain injury (TBI), sponsored by Zhangjiagang First People's Hospital. Started Mar 2026; status: recruiting.
02
Drugs
methylprednisolone injection
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT07180277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07180277.